Determinants of long-term response to group therapy for dysfunctional fear of progression in chronic diseases

Behavioral Medicine

Volumn 38, Issue 1, 2012, Pages 1-5

  Dinkel, Andreas ^a   Herschbach, Peter ^a   Berg, Petra ^b   Waadt, Sabine ^a   Duran, Gabriele ^a   Engst Hastreiter, Ursula ^c   Henrich, Gerhard ^a   Book, Katrin ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Institute for Therapy Research   (Germany)

^c Rheumatology Rehabilitation Center   (Germany)

Author keywords

cancer; fear of progression; group psychotherapy; reliable change index; rheumatic diseases

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CANCER PATIENT; CHRONIC DISEASE; COGNITIVE THERAPY; CONTROLLED STUDY; DISTRESS SYNDROME; DYSFUNCTIONAL FEAR OF PROGRESSION; FEMALE; GROUP THERAPY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SUPPORTIVE EXPERIENTIAL THERAPY; TREATMENT RESPONSE;

ARTHRITIS; CHRONIC DISEASE; COGNITIVE THERAPY; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PHOBIC DISORDERS; PSYCHOTHERAPY, GROUP;

EID: 84858043393     PISSN: 08964289     EISSN: 19404026     Source Type: Journal    
DOI: 10.1080/08964289.2011.640364     Document Type: Article

References (24)

1. Lee-Jones C, Humphris G, Dixon R, Bebbington Hatcher M. Fear of recurrence: a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncol. 1997;6:95-105. (Pubitemid 27288402)
2. Lebel S, Rosberger Z, Edgar L, Devins GM. Comparison of four common stressors across the breast cancer trajectory. J Psychosom Res. 2007;63:225-232. (Pubitemid 47268522)
3. Llewellyn CD, Weinman J, McGurk M, Humphris G. Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res. 2008;65:525-532.
4. Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncol. 2009;18:1273-1280.
5. Skaali T, Fosså SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncol. 2009;18:580-588.
6. Townend E, Tinson D, Kwan J, Sharpe M. Fear of recurrence and beliefs about preventing recurrence in persons who have suffered a stroke. J Psychosom Res. 2006;61:747-755. (Pubitemid 44830040)
7. Bölter AF, Lange J, Anger B, Olbricht S, Köhler M, Frommer J. Wer hat größere Furcht vor einer Verkürzung der Lebensspanne: palliativ oder kurativ behandelte Krebspatienten? [Who has more anxiety concerning a shortened life span: terminal cancer patients or those in curative therapy?] Psychother Psych Med. 2010;60:255-261.
8. Herschbach P, Berg P, Dankert A, et al. Fear of progression in chronic diseases. Psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005;58:505-511. (Pubitemid 41206846)
9. Berg P, Book K, Dinkel A, et al. Progredienzangst bei chronischen Erkrankungen [Fear of progression in chronic diseases]. Psychother Psych Med. 2011;61:32-37.
10. Zimmermann T, Herschbach P, Wessarges M, Heinrichs N. Fear of progression in partners of chronically ill patients. Behav Med. 2011;37:95-104.
11. Dankert A, Duran G, Engst-Hastreiter U, et al. Progredienzangst bei Patienten mit Tumorerkrankungen, Diabetes mellitus und entzündlich- rheumatischen Erkrankungen [Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis]. Rehabil. 2003;42:155-163. (Pubitemid 36827515)
12. Herschbach P, Berg P, Waadt S, et al. Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom. 2010;79:31-38.
13. Herschbach P, Book K, Dinkel A, et al. Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer. 2010;18:471-479.
14. Dinkel A, Henrich G, Herschbach P. Copingeffektivität und Progredienzangst bei Krebskranken [Coping effectiveness and fear of disease progression in cancer patients]. Z Gesundheitspsychol. 2011;19:35-42.
15. Jacobson NS, Truax P. Clinical significance: a statistical approach to definingmeaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12-19.
16. Vamos M. Psychotherapy in the medically ill: a commentary. Aust N Z J Psychiatr. 2006;40:295-309.
17. van Straten A, Geraedts A, Verdonck-de Leeuw I, Andersson G, Cuijpers P. Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res. 2010;69:23-32.
18. Gil KM, Mishel MH, Belyea M, Germino B, Porter LS, Clayton M. Benefits of the uncertainty management intervention for African American andWhite older breast cancer survivors: 20 month outcome. Int J Behav Med. 2006;13:286-294. (Pubitemid 46239731)
19. Watson JC, Gordon LB, Stermac L, Kalogerakos F, Steckley P. Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol. 2003;71:773-781. (Pubitemid 36897411)
20. Lambert MJ, Ogles BM. Using clinical significance in psychotherapy outcome research: the need for a common procedure and validity data. Psychother Res. 2010;19:493-501.
21. Vowles KE, McCracken LM. Acceptance and values-based action in chronic pain: a study of treatment effectiveness and process. J Consult Clin Psychol. 2008;76:397-407. (Pubitemid 351822340)
22. Jellema P, van der Horst HE, Vlaeyen JW, Stalman WA, Bouter LM, van der Windt DA. Predictors of outcome in patients with (sub)acute low back pain differ across treatment groups. Spine. 2006;31:1699-1705. (Pubitemid 43999968)
23. Sinclair VG, Wallston KA. Predictors of improvement in a cognitive-behavioral intervention for women with rheumatoid arthritis. Ann Behav Med. 2001;23:291-297. (Pubitemid 33134835)
24. Hamilton KE, Dobson KS. Cognitive therapy of depression: pretreatment patient predictors of outcome. Clin Psychol Rev. 2002;22:875-893. (Pubitemid 34756742)